Electron Kebebew

10PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMetabolic medicineCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 07, 2023
Combination BRAF Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in BRAF-Mutant Anaplastic Thyroid Cancer.

Viswanath Gunda, Chandrayee Ghosh, Jiangnan Hu

|Nov 23, 2022
Risk of Permanent Hypoparathyroidism Requiring Calcitriol Therapy in a Population-Based Cohort of Adults Older Than 65 Undergoing Total Thyroidectomy for Graves' Disease.

Carolyn Dacey Seib, Tong Meng, Robin M Cisco

|Jan 16, 2020
A Combinatorial Strategy for Targeting BRAF V600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib).

Chandrayee Ghosh, Suresh Kumar, Yevgeniya Kushchayeva

|Apr 26, 2018
Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo.

Shilpa Thakur, Brianna Daley, Kelli Gaskins

Pageof 2